Manufacturer: Novartis manufactures Lamisil Once 4gm.


The uses of Lamisil Once 4gm include:
Therapeutic indications:

1. Onychomycosis (fungal infection of the nail) caused by

dermatophyte fungi.

2. Tinea capitis.

3. Fungal infections of the skin for the treatment of tinea

corporis, tinea cruris, tinea pedis and yeast infections of

the skin caused by the genus Candida (e.g. Candida

albicans) where oral therapy is generally considered

appropriate owing to the site, severity or extent of the


Note: In contrast to topical Lamisil®, oral Lamisil is not effective in pityriasis versicolor.

Skin infections

Recommended duration of treatment:

Tinea pedis (interdigital, plantar/moccasin type): 2 to 6 weeks.

Tinea corporis, cruris: 2 to 4 weeks.

Cutaneous candidiasis: 2 to 4 weeks.

Complete resolution of the signs and symptoms of infection may not occur until several weeks after mycological cure.

Hair and scalp infections

Recommended duration of treatment:

Tinea capitis: 4 weeks.

Tinea capitis occurs primarily in children.


For most patients the duration of successful treatment is 6-12 weeks.

Fingernail onychomycosis

Six weeks of therapy is sufficient for fingernail infections in most cases.

Toenail onychomycosis

Twelve weeks of therapy is sufficient for toenail infections in most cases.

Some patients with poor nail outgrowth may require longer treatment. The optimal clinical effect is seen some months after mycological cure and cessation of treatment. This is related to the period required for outgrowth of healthy nail.